The company added a supplement to its existing Citizen Petition (CP) to the FDA, including the results of a year-long study that, according to the company, demonstrate, ???abuse of the reformulated Opana ER was reduced by 59 percent, based on the total number of prescriptions dispensed, versus the rate observed for the non-tamper-resistant formulation of Opana ER, which is no longer being manufact